ABOUT US
SCIENCE
FACILITY
BUSINESS
INVESTORS
Media
Notice
Public Disclosures
Stock Information
Financials
ESG
ESG Management
Archive
CONTACT
ABOUT US
SCIENCE
FACILITY
BUSINESS
INVESTORS
Media
Notice
Public Disclosures
Stock Information
Financials
ESG
ESG Management
Archive
CONTACT
INVESTORS
[이투데이] “16일 만에 맞춤형 치료제 공급⋯글로벌 CAR-T 넘어선다”
2026/06/22
“16일 만에 맞춤형 치료제 공급⋯글로벌 CAR-T 넘어선다” – 이투데이
Prev
[매경헬스] 김건수 큐로셀 대표 “림카토 허가는 시작… CAR-T 치료제 개발, 고형암으로 확장할 것”
Next
[이투데이] 1회 투약으로 완치 기대⋯‘기적의 항암제’ 국내 최초 산실을 가다
ABOUT US
SCIENCE
FACILITY
BUSINESS
INVESTORS
Media
Notice
Public Disclosures
Stock Information
Financials
ESG
ESG Management
Archive
CONTACT
ABOUT US
SCIENCE
FACILITY
BUSINESS
INVESTORS
Media
Notice
Public Disclosures
Stock Information
Financials
ESG
ESG Management
Archive
CONTACT
Copyright 2023. Curocell Inc. All Rights Reserved.
